Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Stuart M. Sprague & Jürgen Floege. (2018) Sucroferric oxyhydroxide for the treatment of hyperphosphatemia. Expert Opinion on Pharmacotherapy 19:10, pages 1137-1148.
Read now
Read now
Valeria Cernaro, Domenico Santoro, Antonio Lacquaniti, Giuseppe Costantino, Luca Visconti, Antoine Buemi & Michele Buemi. (2016) Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide. International Journal of Nephrology and Renovascular Disease 9, pages 11-19.
Read now
Read now
Rathika Krishnasamy, Carmel M Hawley & David W Johnson. (2016) An update on bone imaging and markers in chronic kidney disease. Expert Review of Endocrinology & Metabolism 11:6, pages 455-466.
Read now
Read now
J. Bover, P. Ureña-Torres, M. J. Lloret, C. Ruiz-García, I. DaSilva, M. M. Diaz-Encarnacion, C. Mercado, S. Mateu, E. Fernández & J. Ballarin. (2016) Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification. Expert Opinion on Pharmacotherapy 17:9, pages 1247-1258.
Read now
Read now
Francesco Locatelli, Nada Dimkovic & Goce Spasovski. (2015) Colestilan for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Expert Review of Endocrinology & Metabolism 10:2, pages 131-142.
Read now
Read now
Articles from other publishers (18)
Hsiao-Tien Chen, Kuo-Chuan Hung, Chin-Wei Hsu, Jui-Yi Chen, Chien-Cheng Liu, I-Wen Chen & Cheuk-Kwan Sun. (2023) The efficacy and safety of cuttlebone for lowering serum phosphate in patients with end-stage renal disease: a meta-analysis of randomized controlled trials. Frontiers in Pharmacology 14.
Crossref
Crossref
Eman Nagy, Mahmoud M. Sobh, Mohamed Abdalbary, Sherouk Elnagar, Rabab Elrefaey, Shimaa Shabaka, Nehal Elshabrawy, Rasha Shemies, Mona Tawfik, Cássia Gomes S. Santos, Fellype C. Barreto & Amr El-Husseini. (2022) Is Adynamic Bone Always a Disease? Lessons from Patients with Chronic Kidney Disease. Journal of Clinical Medicine 11:23, pages 7130.
Crossref
Crossref
Lilio Hu, Angelodaniele Napoletano, Michele Provenzano, Carlo Garofalo, Claudia Bini, Giorgia Comai & Gaetano La Manna. (2022) Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic. International Journal of Molecular Sciences 23:20, pages 12223.
Crossref
Crossref
Jun‐Peng Xu, Rui‐Xiang Zeng, Peng‐Da Liao & Min‐Zhou Zhang. (2021) Effect of lanthanum carbonate on the progression of coronary artery calcification in hemodialysis patients: A meta‐analysis of randomized controlled trials. Hemodialysis International 26:2, pages 223-233.
Crossref
Crossref
Jeerath Phannajit, Natthaphon Wonghakaeo, Kullaya Takkavatakarn, Thanin Asawavichienjinda, Kearkiat Praditpornsilpa, Somchai Eiam-Ong & Paweena Susantitaphong. (2021) The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials. Journal of Nephrology 35:2, pages 473-491.
Crossref
Crossref
Roosa Lankinen, Markus Hakamäki, Tapio Hellman, Niina S. Koivuviita, Kaj Metsärinne & Mikko J. Järvisalo. (2022) Progression of Aortic Calcification in Stage 4–5 Chronic Kidney Disease Patients Transitioning to Dialysis and Transplantation. Kidney and Blood Pressure Research 47:1, pages 23-30.
Crossref
Crossref
Helen Eddington, Rajkumar Chinnadurai, Helen Alderson, Sara T. Ibrahim, Constantina Chrysochou, Darren Green, Ibi Erekosima, Alastair Hutchison, Abdalla Bubtana, Janet Hegarty & Philip A. Kalra. (2021) A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism. BMC Nephrology 22:1.
Crossref
Crossref
Paola Ciceri & Mario Cozzolino. (2021) The emerging role of iron in heart failure and vascular calcification in CKD. Clinical Kidney Journal 14:3, pages 739-745.
Crossref
Crossref
Andrea Galassi, Paola Ciceri, Eliana Fasulo, Stefano Carugo, Giuseppe Cianciolo & Mario Cozzolino. (2019) Management of Secondary Hyperparathyroidism in Chronic Kidney Disease: A Focus on the Elderly. Drugs & Aging 36:10, pages 885-895.
Crossref
Crossref
Carla Viegas, Nuna Araújo, Catarina Marreiros & Dina Simes. (2019) The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts. Aging 11:12, pages 4274-4299.
Crossref
Crossref
Wander Barros do Carmo, Bárbara Bruna Abreu Castro, Clóvis Antônio Rodrigues, Melani Ribeiro Custódio & Helady Sanders-Pinheiro. (2018) Chitosan-Fe (III) Complex as a Phosphate Chelator in Uraemic Rats: A Novel Treatment Option. Basic & Clinical Pharmacology & Toxicology 122:1, pages 120-125.
Crossref
Crossref
Jang-Hee Cho, Hye Min Jang, Hee-Yeon Jung, Ji-Young Choi, Sun-Hee Park, Chan-Duck Kim, Chul Woo Yang, Dong-Chan Jin & Yong-Lim Kim. (2018) A Real-world Cost-effectiveness Analysis of Sevelamer Versus Calcium Acetate in Korean Dialysis Patients. Clinical Therapeutics 40:1, pages 123-134.
Crossref
Crossref
Lin Xu, Shi Lin Lin & C. Mary Schooling. (2017) A Mendelian randomization study of the effect of calcium on coronary artery disease, myocardial infarction and their risk factors. Scientific Reports 7:1.
Crossref
Crossref
Jordi Bover, Pablo Ureña-Torres, José Luis Górriz, María Jesús Lloret, Iara da Silva, César Ruiz-García, Pamela Chang, Mariano Rodríguez & José Ballarín. (2016) Cardiovascular calcifications in chronic kidney disease: Potential therapeutic implications. Nefrología (English Edition) 36:6, pages 597-608.
Crossref
Crossref
Jordi Bover, Pablo Ureña-Torres, José Luis Górriz, María Jesús Lloret, Iara da Silva, César Ruiz-García, Pamela Chang, Mariano Rodríguez & José Ballarín. (2016) Calcificaciones cardiovasculares en la enfermedad renal crónica: Potenciales implicaciones terapéuticas. Nefrología 36:6, pages 597-608.
Crossref
Crossref
Sabine Rohrmann, Hans Garmo, Håkan Malmström, Niklas Hammar, Ingmar Jungner, Göran Walldius & Mieke Van Hemelrijck. (2016) Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS study. Atherosclerosis 251, pages 85-93.
Crossref
Crossref
J Ruth Wu-Wong, Yung-wu Chen, Jonathan T Wong & Jerry L Wessale. (2016) Preclinical studies of VS-505: a non-absorbable highly effective phosphate binder. British Journal of Pharmacology 173:14, pages 2278-2289.
Crossref
Crossref
Kyung Sun Park, Jongha Park, Seong Hoon Choi, Seo Hee Ann, Gillian Balbir Singh, Eun-Seok Shin, Jong Soo Lee & Hyun Chul Chung. (2016) Serum Phosphorus Concentration and Coronary Artery Calcification in Subjects without Renal Dysfunction. PLOS ONE 11:3, pages e0151007.
Crossref
Crossref